BE MOBILE 2: Bimekizumab in patients with active ankylosing spondylitis
/ Désirée van der Heijde
COVID-19 and the future management of patients with rheumatological disorders
/ Maria-Antonietta D’Agostino
We make sure to keep you updated from EULAR 2022
/ BestPractice Nordic